RxDoctor Payments Data

Jennifer Haigis, APRN

Nurse Practitioner · Covington, KYNPI 1376989533

Payments from drug & device makers

$921in general payments, 2019–2025

Across 46 payments — averaging $20.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$125
  • Pfizer$104
  • Exact Sciences$95
  • AbbVie$89
  • Merck$62
  • Axsome Therapeutics, Inc.$55
  • plus $391 from 12 others

What the payments were for

  • Food & beverage$921100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$921 in reported general payments places this provider in the 65th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$22,515
Medicare patients
126
Services billed
1,434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban65$55,760
OzempicSemaglutide35$51,767
LinzessLinaclotide19$30,219
Breztri AerosphereBudesonide/Glycopyr/Formoterol32$24,759
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$21,956
JanuviaSitagliptin Phosphate27$20,963
MounjaroTirzepatide15$16,123
XareltoRivaroxaban16$12,099
TradjentaLinagliptin11$10,772
SymbicortBudesonide/Formoterol Fumarate16$7,260
VeozahFezolinetant11$6,051
Lantus SolostarInsulin Glargine,hum.Rec.Anlog32$5,633
Albuterol Sulfate HfaAlbuterol Sulfate100$2,709
Gabapentin223$2,593
Duloxetine Hcl123$2,521

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$104$55,76065 claims
AbbVieLinzess$89$30,21919 claims
MerckJanuvia$62$20,96327 claims
Lilly USA, LLCMounjaro$44$16,12315 claims
Johnson & JohnsonXarelto$39$12,09916 claims
Astellas Pharma US IncVeozah$54$6,05111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Covington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →